A. Lavolé

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster et al. · The Lancet · 2011 · 573 citations

Elderly Patients, Medicine, Metronomic Therapy +7

Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia

Vincent Cottin, Thierry Chinet, A. Lavolé et al. · Medicine · 2007 · 213 citations · Full text

Cardiovascular Disease, Pulmonary Arteriovenous Malformations, Hematology +15

Six-month prognosis of patients with lung cancer admitted to the intensive care unit

Sébastien Roques, Antoine Parrot, A. Lavolé et al. · Intensive Care Medicine · 2009 · 120 citations

Prognostic Evaluation, Critical Care Medicine, Intensive Care Unit +8

Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort

Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier et al. · Clinical Infectious Diseases · 2013 · 120 citations · Full text

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

Marie Wislez, Julien Mazières, A. Lavolé et al. · Journal for ImmunoTherapy of Cancer · 2022 · 108 citations · Full text